Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Not treating pregnant women with malaria 'not an option'

Dr Joel Tarning from MORU discusses his New England Journal of Medicine editorial on treating malaria in pregnancy, outlining new evidence on the effectiveness of artemisinin-combination therapies in pregnant women with malaria.

Researcher and a patient

The full story is available on the NPR website

Similar stories

Simple new method that measures viral clearance means antibody treatments for COVID and ‘flu can be quickly assessed for effectiveness, say MORU researchers

Measuring the rate of viral clearance from the back of the mouth in patients with mild infections can be used to determine quickly and inexpensively if an antibody is effective in future COVID-19, influenza and other respiratory virus pandemics, say researchers in a letter published today in The Lancet.

15 emerging Asian global health researchers selected to join MODRA

Real-time genetic surveillance can support timely, evidence-based responses to shifting malaria threats

Landmark DeTACT project holds final Investigators’ meeting

Building Better Vaccines: Dr Thitinan Kitisin Explores Tonsil Organoids Models in Thailand

MORU-Oxford Engagement Meeting